VITASPRING BIOMEDICAL CO., LTD. (VSBC) Net margin 2018–2022
VITASPRING BIOMEDICAL CO., LTD. (VSBC) net profit margin by fiscal year — reported net income divided by reported revenue.
16.2%FY2022 · since FY2018: -39.3% → 16.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2022 | 16.2% | -155.2 pp |
| FY2021 | 171.4% | +125.7 pp |
| FY2020 | 45.7% | +176.1 pp |
| FY2019 | -130.4% | -91.1 pp |
| FY2018 | -39.3% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More VSBC financial trends
VSBC RevenueVSBC Net incomeVSBC Gross profitVSBC Gross marginVSBC Operating incomeVSBC Operating marginVSBC Operating cash flowVSBC Free cash flowVSBC Capital expendituresVSBC Return on equityVSBC Stock buybacksVSBC Dividends paidVSBC Total assetsVSBC Total liabilitiesVSBC Shareholders’ equityVSBC overview →